These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22222817)

  • 101. HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS.
    Eugenin EA; Dyer G; Calderon TM; Berman JW
    Glia; 2005 Mar; 49(4):501-10. PubMed ID: 15578658
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Chemokine signaling involving chemokine (C-C motif) ligand 2 plays a role in descending pain facilitation.
    Guo W; Wang H; Zou S; Dubner R; Ren K
    Neurosci Bull; 2012 Apr; 28(2):193-207. PubMed ID: 22466130
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Effect of olfactory ensheathing cells combined with chitosan on inhibition of P2×4 receptor over-expression-mediated neuropathic pain.
    Zhang WJ; Luo HL; Zhu ZM
    Neurosci Lett; 2020 Mar; 722():134859. PubMed ID: 32097702
    [TBL] [Abstract][Full Text] [Related]  

  • 104. P2X4 Receptors Mediate Ca
    Tan SL; Barri M; Atakpa-Adaji P; Taylor CW; St John Smith E; Murrell-Lagnado RD
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638832
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Characterization of the antagonist actions of 5-BDBD at the rat P2X4 receptor.
    Coddou C; Sandoval R; Hevia MJ; Stojilkovic SS
    Neurosci Lett; 2019 Jan; 690():219-224. PubMed ID: 30366010
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development.
    Biber K; Tsuda M; Tozaki-Saitoh H; Tsukamoto K; Toyomitsu E; Masuda T; Boddeke H; Inoue K
    EMBO J; 2011 May; 30(9):1864-73. PubMed ID: 21441897
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Sociocommunicative and sensorimotor impairments in male P2X4-deficient mice.
    Wyatt LR; Godar SC; Khoja S; Jakowec MW; Alkana RL; Bortolato M; Davies DL
    Neuropsychopharmacology; 2013 Sep; 38(10):1993-2002. PubMed ID: 23604007
    [TBL] [Abstract][Full Text] [Related]  

  • 108. P2X4R+ microglia drive neuropathic pain.
    Beggs S; Trang T; Salter MW
    Nat Neurosci; 2012 Jul; 15(8):1068-73. PubMed ID: 22837036
    [TBL] [Abstract][Full Text] [Related]  

  • 109. P2X4R Contributes to Central Disinhibition Via TNF-α/TNFR1/GABAaR Pathway in Post-stroke Pain Rats.
    Lu J; Guo X; Yan M; Yuan X; Chen S; Wang Y; Zhu J; Huang S; Shen H; Li H; Xue Q; Fang Q; Ni J; Gan L; Zhao H; Lu H; Chen G
    J Pain; 2021 Aug; 22(8):968-980. PubMed ID: 33677111
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Catestatin enhances ATP-induced activation of glial cells mediated by purinergic receptor P2X
    Du E; Wang A; Fan R; Rong L; Yang R; Xing J; Shi X; Qiao B; Yu R; Xu C
    J Recept Signal Transduct Res; 2022 Apr; 42(2):160-168. PubMed ID: 33504266
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Macrophage P2X4 receptors augment bacterial killing and protect against sepsis.
    Csóka B; Németh ZH; Szabó I; Davies DL; Varga ZV; Pálóczi J; Falzoni S; Di Virgilio F; Muramatsu R; Yamashita T; Pacher P; Haskó G
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875325
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis.
    Di Salvo C; D'Antongiovanni V; Benvenuti L; Fornai M; Valdiserra G; Natale G; Ryskalin L; Lucarini E; Mannelli LDC; Ghelardini C; Colucci R; Haskó G; Pellegrini C; Antonioli L
    J Drug Target; 2024 Sep; 32(8):953-963. PubMed ID: 38864378
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Microglial migration mediated by ATP-induced ATP release from lysosomes.
    Dou Y; Wu HJ; Li HQ; Qin S; Wang YE; Li J; Lou HF; Chen Z; Li XM; Luo QM; Duan S
    Cell Res; 2012 Jun; 22(6):1022-33. PubMed ID: 22231629
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Improvement of the affinity of an anti-rat P2X4 receptor antibody by introducing electrostatic interactions.
    Shinozaki C; Kohno K; Shiroishi M; Takahashi D; Yoshikawa Y; Abe Y; Hamase K; Nakakido M; Tsumoto K; Inoue K; Tsuda M; Ueda T
    Sci Rep; 2022 Jan; 12(1):131. PubMed ID: 34996944
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Tryptophan 46 is a site for ethanol and ivermectin action in P2X4 receptors.
    Popova M; Trudell J; Li K; Alkana R; Davies D; Asatryan L
    Purinergic Signal; 2013 Dec; 9(4):621-32. PubMed ID: 23817978
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Microglial Activation Modulated by P2X4R in Ischemia and Repercussions in Alzheimer's Disease.
    Castillo C; Saez-Orellana F; Godoy PA; Fuentealba J
    Front Physiol; 2022; 13():814999. PubMed ID: 35283778
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Overview for the study of P2 receptors: From P2 receptor history to neuropathic pain studies.
    Inoue K
    J Pharmacol Sci; 2022 Jul; 149(3):73-80. PubMed ID: 35641030
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Contribution of P2X4 receptor in pain associated with rheumatoid arthritis: a review.
    Khir NAM; Noh ASM; Shafin N; Ismail CAN
    Purinergic Signal; 2021 Jun; 17(2):201-213. PubMed ID: 33594635
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Contribution of P2X4 receptors to ethanol intake in male C57BL/6 mice.
    Wyatt LR; Finn DA; Khoja S; Yardley MM; Asatryan L; Alkana RL; Davies DL
    Neurochem Res; 2014 Jun; 39(6):1127-39. PubMed ID: 24671605
    [TBL] [Abstract][Full Text] [Related]  

  • 120. P2X4 receptor participates in autophagy regulation in Parkinson's disease.
    Zhang X; Wang J; Gao JZ; Zhang XN; Dou KX; Shi WD; Xie AM
    Neural Regen Res; 2021 Dec; 16(12):2505-2511. PubMed ID: 33907041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.